Mark Linch
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Vascular Tumors and Angiosarcomas
-
- Sarcoma Diagnosis and Treatment
Papers in
- Oncology 42
- Cancer Immunotherapy and Biomarkers 27
- Peptidase Inhibition and Analysis 7
-
- Prostate Cancer Treatment and Research 19
- Co-authors
- Peter J. Parker (13 shared papers)Carine Rossé (7 shared papers)Angus J.M. Cameron (6 shared papers)Katrina Boeckeler (2 shared papers)Stéphanie Kermorgant (1 shared paper)Charlotte Benson (7 shared papers)Aisha Miah (5 shared papers)Ian Judson (6 shared papers)
- Journals
- Journal of Clinical Oncology (22 papers)Annals of Oncology (8 papers)Sarcoma (3 papers)European Urology (2 papers)Biochemical Journal (2 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Mark Linch
72 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 116
- Oncology 690
- Pulmonary and Respiratory Medicine 492
- Cell Biology 236
- Cancer Research 202
- Molecular Biology 887
Countries citing papers authored by Mark Linch
This map shows the geographic impact of Mark Linch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Linch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Linch more than expected).
Fields of papers citing papers by Mark Linch
This network shows the impact of papers produced by Mark Linch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Linch. The network helps show where Mark Linch may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Linch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 347 | |
| 2 | 2014 | 169 | |
| 3 | 2019 | 133 | |
| 4 | 2009 | 86 | |
| 5 | 2014 | 78 | |
| 6 | 2013 | 76 | |
| 7 | 2017 | 70 | |
| 8 | 2011 | 67 | |
| 9 | 2018 | 63 | |
| 10 | 2013 | 50 | |
| 11 | 2013 | 48 | |
| 12 | 2006 | 46 | |
| 13 | 2016 | 43 | |
| 14 | 2019 | 42 | |
| 15 | 2020 | 41 | |
| 16 | 2011 | 40 | |
| 17 | 2020 | 35 | |
| 18 | 2019 | 28 | |
| 19 | 2017 | 27 | |
| 20 | 2021 | 27 |
About Mark Linch
Mark Linch is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Radiology, Nuclear Medicine and Imaging, having authored 74 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (27 papers), Prostate Cancer Treatment and Research (19 papers), Bladder and Urothelial Cancer Treatments (14 papers), Protein Kinase Regulation and GTPase Signaling (10 papers), Urinary and Genital Oncology Studies (8 papers), PI3K/AKT/mTOR signaling in cancer (7 papers), Peptidase Inhibition and Analysis (7 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). The work is most often cited by research in Oncology (690 citations), Pulmonary and Respiratory Medicine (492 citations), Cell Biology (236 citations), Cancer Research (202 citations) and Molecular Biology (887 citations). Mark Linch has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Peter J. Parker, Carine Rossé, Angus J.M. Cameron, Katrina Boeckeler, Stéphanie Kermorgant, Charlotte Benson, Aisha Miah, Ian Judson, Thomas Powles and Khin Thway. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Sarcoma, European Urology and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.